U.S. federal trademark · Serial No. 90977927 · Reg. No. 6919717
Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, respiratory tract infections including COVID-19, Influenza A, Influenza A + B, Strep A, Respiratory Syncytial Virus Antigen (RSV), Adenovirus pneumonia Antigen, Legionella pneumophilia, Streptococcus pneumoniae, Mycoplasma pneumonia Antigen and Antibody, Mononucleosis (MONO) and EBV VCA IgB and EBNA IgG; Diagnostic kits comprised of medical diagnostic assays for use in disease detection and screening related to COVID-19; Respiratory rapid tests, namely, diagnostic assays for use in performing respiratory rapid diagnostic tests for detecting COVID-19; Screening tests and devices to detect COVID-19 in a patient, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection related to COVID-19
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.